Tamás Ágh1, Péterné Dömötör2, Zoltán Bártfai3, András Inotai4, Eszter Fujsz3, Ágnes Mészáros5. 1. Syreon Research Institute, Budapest, Hungary. tamas.agh@syreon.eu. 2. Department of Pulmonology, Elisabeth Teaching Hospital and Rehabilitation Institute Sopron, Sopron, Hungary. Faculty of Economics, University of West Hungary, Sopron, Hungary. 3. Department of Pulmonology, Elisabeth Teaching Hospital and Rehabilitation Institute Sopron, Sopron, Hungary. 4. Syreon Research Institute, Budapest, Hungary. 5. University Pharmacy Department of Pharmacy Administration, Semmelweis University, Budapest, Hungary.
Abstract
BACKGROUND: Various aspects of medication adherence and health-related quality of life (HRQOL) have been studied in subjects with COPD. Nevertheless, little is known about the association between these factors. The aim of this study was to undertake a systematic review of the published literature focusing on the relationship between medication adherence and HRQOL in COPD. METHODS: A systematic literature search of English language articles was conducted in April 2013 using MEDLINE. No publication date limits were defined. All of the included studies were assessed for quality. RESULTS: Seven studies were included in the review. Three of the assessed studies found no correlation, and 3 studies described positive and 2 studies reported negative associations between medication adherence and HRQOL. The results indicate that an improved HRQOL may be a trigger for non-adherence in patients with COPD. CONCLUSIONS: The relationship between medication adherence and HRQOL may be dual. The effect of medication adherence on HRQOL might be a consequence of the effectiveness of therapy and the negative effects (ie, side effects, daily life limitation of therapy, social stigma) that it can generate. HRQOL might also influence the patterns of patients' drug use, as an increased HRQOL might trigger non-adherence. The dynamics between adherence and HRQOL might differ over time, as the negative effects of medication non-adherence might become dominant in the long term.
BACKGROUND: Various aspects of medication adherence and health-related quality of life (HRQOL) have been studied in subjects with COPD. Nevertheless, little is known about the association between these factors. The aim of this study was to undertake a systematic review of the published literature focusing on the relationship between medication adherence and HRQOL in COPD. METHODS: A systematic literature search of English language articles was conducted in April 2013 using MEDLINE. No publication date limits were defined. All of the included studies were assessed for quality. RESULTS: Seven studies were included in the review. Three of the assessed studies found no correlation, and 3 studies described positive and 2 studies reported negative associations between medication adherence and HRQOL. The results indicate that an improved HRQOL may be a trigger for non-adherence in patients with COPD. CONCLUSIONS: The relationship between medication adherence and HRQOL may be dual. The effect of medication adherence on HRQOL might be a consequence of the effectiveness of therapy and the negative effects (ie, side effects, daily life limitation of therapy, social stigma) that it can generate. HRQOL might also influence the patterns of patients' drug use, as an increased HRQOL might trigger non-adherence. The dynamics between adherence and HRQOL might differ over time, as the negative effects of medication non-adherence might become dominant in the long term.
Authors: Kirsten Koehorst-Ter Huurne; Sharina Kort; Job van der Palen; Wendy Jc van Beurden; Kris Ll Movig; Paul van der Valk; Marjolein Brusse-Keizer Journal: Int J Chron Obstruct Pulmon Dis Date: 2016-07-26